Anti-Inflammatory Agents, Non-Steroidal
"Anti-Inflammatory Agents, Non-Steroidal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
| Descriptor ID |
D000894
|
| MeSH Number(s) |
D27.505.696.663.850.014.040.500 D27.505.954.158.030 D27.505.954.329.030
|
| Concept/Terms |
Anti-Inflammatory Agents, Non-Steroidal- Anti-Inflammatory Agents, Non-Steroidal
- Antiinflammatory Agents, Non Steroidal
- NSAIDs
- Non-Steroidal Anti-Inflammatory Agents
- Non Steroidal Anti Inflammatory Agents
- Nonsteroidal Anti-Inflammatory Agents
- Nonsteroidal Anti Inflammatory Agents
- Anti Inflammatory Agents, Nonsteroidal
- Antiinflammatory Agents, Nonsteroidal
- Nonsteroidal Antiinflammatory Agents
|
Below are MeSH descriptors whose meaning is more general than "Anti-Inflammatory Agents, Non-Steroidal".
Below are MeSH descriptors whose meaning is more specific than "Anti-Inflammatory Agents, Non-Steroidal".
This graph shows the total number of publications written about "Anti-Inflammatory Agents, Non-Steroidal" by people in this website by year, and whether "Anti-Inflammatory Agents, Non-Steroidal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 2 | 0 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 4 | 0 | 4 |
| 1999 | 5 | 3 | 8 |
| 2000 | 4 | 4 | 8 |
| 2001 | 3 | 5 | 8 |
| 2002 | 2 | 4 | 6 |
| 2003 | 8 | 3 | 11 |
| 2004 | 4 | 4 | 8 |
| 2005 | 9 | 1 | 10 |
| 2006 | 3 | 5 | 8 |
| 2007 | 6 | 1 | 7 |
| 2008 | 8 | 3 | 11 |
| 2009 | 3 | 1 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 4 | 1 | 5 |
| 2012 | 10 | 4 | 14 |
| 2013 | 8 | 2 | 10 |
| 2014 | 7 | 4 | 11 |
| 2015 | 3 | 3 | 6 |
| 2016 | 4 | 3 | 7 |
| 2017 | 3 | 3 | 6 |
| 2018 | 2 | 3 | 5 |
| 2019 | 4 | 7 | 11 |
| 2020 | 3 | 5 | 8 |
| 2021 | 2 | 1 | 3 |
| 2022 | 1 | 5 | 6 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Inflammatory Agents, Non-Steroidal" by people in Profiles.
-
Factors associated with long-term clinical outcome in microscopic colitis. Ann Med. 2024 Dec; 56(1):2365989.
-
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial. JAMA. 2024 05 28; 331(20):1714-1721.
-
Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain. Am J Obstet Gynecol. 2024 05; 230(5):553.e1-553.e14.
-
Reply to Comment on: Noninfectious Outcomes of Intravitreal Antibiotic-Steroid Injection and Topical NSAID Versus Triple Drop Therapy Postcataract Surgery. Am J Ophthalmol. 2024 04; 260:215-216.
-
Noninfectious Outcomes of Intravitreal Antibiotic Steroid Injection and Topical Nonsteroidal Antiinflammatory Drugs Versus Triple Drop Therapy After Cataract Surgery. Am J Ophthalmol. 2024 04; 260:37-48.
-
Use of nonsteroidal anti-inflammatory drugs and poor olfaction in women. Int Forum Allergy Rhinol. 2024 Mar; 14(3):639-650.
-
The association of out-of-hospital postpartum NSAID use and post-discharge hypertension control for people with hypertensive disorders of pregnancy. Pregnancy Hypertens. 2023 Sep; 33:34-38.
-
Effects of systemic drugs on the development and progression of age-related macular degeneration. Surv Ophthalmol. 2023 May-Jun; 68(3):332-346.
-
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy. Eur Heart J. 2022 09 21; 43(36):3477-3489.
-
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial. J Am Acad Dermatol. 2023 01; 88(1):40-51.